Compare LDOS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LDOS | SNN |
|---|---|---|
| Founded | 1969 | 1856 |
| Country | United States | United Kingdom |
| Employees | 47000 | 16988 |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0B | 14.3B |
| IPO Year | 2005 | N/A |
| Metric | LDOS | SNN |
|---|---|---|
| Price | $125.98 | $30.56 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 2 |
| Target Price | ★ $203.15 | $36.25 |
| AVG Volume (30 Days) | 1.2M | ★ 1.3M |
| Earning Date | 05-05-2026 | 03-16-2026 |
| Dividend Yield | 1.18% | ★ 2.48% |
| EPS Growth | ★ 20.82 | N/A |
| EPS | ★ 2.56 | N/A |
| Revenue | ★ $17,174,000,000.00 | N/A |
| Revenue This Year | $6.50 | $8.58 |
| Revenue Next Year | $4.40 | $5.60 |
| P/E Ratio | ★ $48.03 | $64.97 |
| Revenue Growth | ★ 3.07 | N/A |
| 52 Week Low | $121.20 | $28.40 |
| 52 Week High | $205.77 | $38.79 |
| Indicator | LDOS | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 31.90 | 45.77 |
| Support Level | $121.53 | $29.08 |
| Resistance Level | $195.71 | $33.89 |
| Average True Range (ATR) | 5.18 | 0.55 |
| MACD | 0.13 | 0.17 |
| Stochastic Oscillator | 14.66 | 58.47 |
Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health management, both domestically and internationally. The customers of the company includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.